arrow
M

Monika Engelhardt

University of Freiburg
H指数:62
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN)

新诊断多发性骨髓瘤维持治疗格局的变化:欧洲骨髓瘤网络(EMN)的系统评价与网络荟萃分析

2026-06-180
OAAI
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma

欧洲骨髓瘤网络工作组关于下一代测序在 newly diagnosed multiple myeloma 预后分层中应用的共识声明

2025-10-130
OAAI
Prevention and treatment of venous thromboembolism in patients with multiple myeloma: Clinical practice guidelines on behalf of the European Myeloma Network

多发性骨髓瘤患者静脉血栓栓塞症的预防与治疗:欧洲骨髓瘤网络临床实践指南

2025-08-260
OAAI
EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma

Eha-emn循证指南用于多发性骨髓瘤患者的诊断、治疗和随访

2025-07-070
PREAI
Optimising T-cell immunotherapy in patients with multiple myeloma: practical considerations from the European Myeloma Network

优化多发性骨髓瘤患者的T细胞免疫疗法:欧洲骨髓瘤网络的经验与考量

2025-06-250
PRE
Analysis of skeletal pain, general symptoms and patient-reported outcome measures and their value in detecting symptomatic progression – An interdisciplinary prospective study in patients with multiple myeloma

骨骼疼痛、一般症状及患者报告结局指标的分析及其在检测症状性进展中的价值——一项针对多发性骨髓瘤患者的跨学科前瞻性研究

2025-06-010
OA
European Myeloma Network Group review and consensus statement on primary plasma cell leukemia

欧洲骨髓瘤网络小组关于原发性浆细胞白血病的综述与共识声明

2025-02-011
PRE
Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple Myeloma

感染或疫苗接种后SARS-CoV-2-Specific CD8 T细胞受损,但多发性骨髓瘤患者的混合T细胞免疫功能强大

2024-11-010
OAAI
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities
2024-06-281
OAAI